Download this on demand presentation detailing our drug substance manufacturing and drug product fill/finish capabilities.
Simplify your GENE to IND timelines with us:
Hear from Nithin Stephen, Director, Commercial Development Drug Product, on how Resilience can support your development & GMP manufacturing needs.
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives by continuously advancing the science of biopharmaceutical manufacturing and development.